Dipeptidyl peptidase-4 inhibitor anagliptin reduces fasting apolipoprotein B-48 levels in patients w...
Dipeptidyl peptidase-4 inhibitor anagliptin reduces fasting apolipoprotein B-48 levels in patients with type 2 diabetes: A randomized controlled trial
About this item
Full title
Author / Creator
Onoue, Takeshi , Goto, Motomitsu , Wada, Eri , Furukawa, Mariko , Okuji, Takayuki , Okada, Norio , Kobayashi, Tomoko , Iwama, Shintaro , Sugiyama, Mariko , Tsunekawa, Taku , Takagi, Hiroshi , Hagiwara, Daisuke , Ito, Yoshihiro , Morishita, Yoshiaki , Seino, Yusuke , Suga, Hidetaka , Banno, Ryoichi , Hamada, Yoji , Ando, Masahiko , Yamamori, Etsuko and Arima, Hiroshi
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Type 2 diabetes and dyslipidemia are diseases that collectively increase the risk of patients developing cardiovascular complications. Several incretin-based drugs are reported to improve lipid metabolism, and one of these medications, anagliptin, is a dipeptidyl peptidase-4 (DPP-4) inhibitor that has been shown to decrease serum triglyceride and l...
Alternative Titles
Full title
Dipeptidyl peptidase-4 inhibitor anagliptin reduces fasting apolipoprotein B-48 levels in patients with type 2 diabetes: A randomized controlled trial
Authors, Artists and Contributors
Author / Creator
Goto, Motomitsu
Wada, Eri
Furukawa, Mariko
Okuji, Takayuki
Okada, Norio
Kobayashi, Tomoko
Iwama, Shintaro
Sugiyama, Mariko
Tsunekawa, Taku
Takagi, Hiroshi
Hagiwara, Daisuke
Ito, Yoshihiro
Morishita, Yoshiaki
Seino, Yusuke
Suga, Hidetaka
Banno, Ryoichi
Hamada, Yoji
Ando, Masahiko
Yamamori, Etsuko
Arima, Hiroshi
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2348098027
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2348098027
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0228004
